Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: ANTIBODY-DRUG CONJUGATE WITH A TUBULYSIN ANALOG WARHEAD HAVING A STABILIZED ACETATE GROUP IN THE TUV SUBUNIT Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 26 Dec 2019 |
Grant | Utility: Compositions comprising a combination of nivolumab and ipilimumab Filling date: 6 Sep 2025 Issue date: 24 Dec 2019 |
Application | Utility: SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLE CARBOXAMIDE COMPOUNDS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANTI-CD137 Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Modified FGF-21 Polypeptides and Uses Thereof Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: NOVEL SUBSTITUTED GLYCINE DERIVED FXIA INHIBITORS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: DERIVATIVES OF UNCIALAMYCIN, METHODS OF SYNTHESIS AND THEIR USE AS ANTITUMOR AGENTS Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: USE OF ANTI-CTLA-4 ANTIBODIES WITH ENHANCED ADCC TO ENHANCE IMMUNE RESPONSE TO A VACCINE Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Methods of Selecting Therapeutic Molecules Filling date: 6 Sep 2025 Issue date: 19 Dec 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 17 Dec 2019 |
Grant | Utility: 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists Filling date: 6 Sep 2025 Issue date: 17 Dec 2019 |
Grant | Utility: Substituted nitrogen containing compounds Filling date: 6 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Filling date: 6 Sep 2025 Issue date: 10 Dec 2019 |
Grant | Utility: Selective NR2B antagonists Filling date: 6 Sep 2025 Issue date: 10 Dec 2019 |
Application | Utility: BIARYL KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: Anti-ICOS agonist antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Hepatitis C virus inhibitors Filling date: 6 Sep 2025 Issue date: 3 Dec 2019 |
Grant | Utility: Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma Filling date: 6 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: ANTIPROLIFERATIVE COMPOUNDS AND CONJUGATES MADE THEREFROM Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE Filling date: 6 Sep 2025 Issue date: 28 Nov 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: Macrocycles as factor XIa inhibitors Filling date: 6 Sep 2025 Issue date: 26 Nov 2019 |
Grant | Utility: Methods for treating patients at risk for costimulation blockade resistant rejection with belatacept Filling date: 6 Sep 2025 Issue date: 26 Nov 2019 |
Application | Utility: TRICYCLIC SULFONE COMPOUND AS A ROR GAMMA MODULATOR Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: COMPOUNDS USEFUL AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Filling date: 6 Sep 2025 Issue date: 21 Nov 2019 |
Grant | Utility: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Grant | Utility: Antibodies to CD40 with enhanced agonist activity Filling date: 6 Sep 2025 Issue date: 19 Nov 2019 |
Application | Utility: NOVEL PD-L1 BINDING POLYPEPTIDES FOR IMAGING Filling date: 6 Sep 2025 Issue date: 14 Nov 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 12 Nov 2019 |
Application | Utility: METHODS FOR THE SELECTION OF BINDING PROTEINS Filling date: 6 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: TGF BETA RECEPTOR ANTAGONISTS Filling date: 6 Sep 2025 Issue date: 7 Nov 2019 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Filling date: 6 Sep 2025 Issue date: 5 Nov 2019 |
Grant | Utility: Fibronectin binding domains with reduced immunogenicity Filling date: 6 Sep 2025 Issue date: 5 Nov 2019 |
Application | Utility: 4-HYDROXY-3-SULFONYLPYRIDIN-2(1H)-ONES AS APJ RECEPTOR AGONISTS Filling date: 6 Sep 2025 Issue date: 31 Oct 2019 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 29 Oct 2019 |
Application | Utility: NOVEL PHOSPHOROUS (V)-BASED REAGENTS, PROCESSES FOR THE PREPARATION THEREOF, AND THEIR USE IN MAKING STEREO-DEFINED ORGANOPHOSHOROUS (V) COMPOUNDS Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: HETEROBICYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: SPIROLACTAMS AS INHIBITORS OF ROCK Filling date: 6 Sep 2025 Issue date: 24 Oct 2019 |
Grant | Utility: Method of using human FC-bearing IGG antibodies to polyethylene glycol Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: CXCR4 receptor antagonists Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Grant | Utility: Stabilized fibronectin based scaffold molecules Filling date: 6 Sep 2025 Issue date: 22 Oct 2019 |
Showing 650 to 700 of 772 patents.